Wilmer Sibbitt, MD
Enriched profileProfessor of Rheumatology, Internal Medicine, and Neurology; Director of Rheumatologic Ultrasound · University of New Mexico Health Sciences Center
Wilmer Sibbitt is Professor of Rheumatology, Internal Medicine, and Neurology; Director of Rheumatologic Ultrasound at University of New Mexico Health Sciences Center. OpenAlex indexes 227 publications with 7,017 citations (h-index 47); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 11 Oct 2026
Overview
Updated 14 Oct 2026
Wilmer Sibbitt, MD, is Professor of Rheumatology, Internal Medicine, and Neurology at University of New Mexico Health Sciences Center. The public record shows 227 publications with 7,017 citations (h-index 47), centered on Systemic Lupus Erythematosus Research, Advanced MRI Techniques and Applications, Vasculitis and related conditions. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 17 companies, 1 NIH-funded awards (1998–2000).
- Most recent indexed publication: 2026 · Rheumatology (Oxford, England)
- Top research focus: Systemic Lupus Erythematosus Research
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 17 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 15 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 121.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Reciprocating Medical Devices - a Study of a New Safety Device
Sponsor: University of New Mexico
Industry payments
Updated 14 Oct 2026
17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year20253 payments
- Amgen Inc.Program year20253 payments
- ABBVIE INC.Program year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.1%TNF inhibitor21.4%Humira(Cf) Pen100%Part D<11 patientsSelective T Cell Costimulation Modulator16.7%Orencia Clickject100%Part D<11 patientsNervous system
34.5%Gabapentinoids17.9%Pregabalin100%Part D<11 patientsBenzodiazepine16.7%Lorazepam100%Part D<11 patientsAntiparasitic
27.4%Antimalarial27.4%Hydroxychloroquine Sulfate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
1 NIH research award on record, funded 1998–2000 per NIH RePORTER. The latest:
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- All-cause mortality in statin-associated immune-mediated necrotizing myopathy compared with idiopathic inflammatory myopathy.
Rheumatology (Oxford, England)
Article2026 - Increased prevalence and incidence of statin-associated immune-mediated necrotizing myopathy in Native Americans.
Rheumatology (Oxford, England)
Article2026 - Topical nonsteroidal anti-inflammatory drug patches for osteoarthritis.
Journal of orthopaedic research
Letter2024 - Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis.
Journal of inflammation research
Review2023 - Machine learning and magnetic resonance imaging: Differentiating benign from malignant osseous tumors.
Journal of clinical ultrasound
Article2023
Most-cited works
by citation count (OpenAlex)- 01Enhancement of natural cytotoxicity by beta-endorphin.Article461 citations1983
- 02
- 03Neuroimaging in neuropsychiatric systemic lupus erythematosusArticle207 citations1999
- 04Does Sonographic Needle Guidance Affect the Clinical Outcome of Intraarticular Injections?Article204 citations2009
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/wilmer-sibbitt-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hsc.unm.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hsc.unm.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hsc.unm.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hsc.unm.edu ↗
Editorial & leadership roles
journal and society appointments- Chair
Pharmacy and Therapeutics Committee, University of New Mexico Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hsc.unm.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital